Group items tagged

Beta-Tricalcium Phosphate (β-TCP) is a bioresorbable synthetic bone graft material used in orthopedic, dental, and spinal surgeries. Known for its high biocompatibility, β-TCP promotes natural bone regeneration by gradually being replaced with new bone tissue. It is widely used for its excellent osteoconductive properties, making it an ideal choice for bone repair and reconstruction.

The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth. Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.